Weizhen Liu
- Biological Psychiatry top 10%
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 11
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 7
- Behavioral Neuroscience top 10%
- Oncology top 10%
-
- Gastric Cancer Management and Outcomes 8
- Sarcoma Diagnosis and Treatment 5
-
- RNA modifications and cancer 6
- RNA Research and Splicing 5
- Ubiquitin and proteasome pathways 4
-
- Cancer Mechanisms and Therapy 5
- Co-authors
- Kaixiong TaoXiangyu ZengChuanqing WuTuo RuanYuping YinChristian HölscherXiaojie ZhuLin Li
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Weizhen Liu
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 105
- Biological Psychiatry 41
- Gastroenterology 82
- Cancer Research 202
- Behavioral Neuroscience 43
- Oncology 301
Countries citing papers authored by Weizhen Liu
This map shows the geographic impact of Weizhen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhen Liu more than expected).
Fields of papers citing papers by Weizhen Liu
This network shows the impact of papers produced by Weizhen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhen Liu. The network helps show where Weizhen Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weizhen Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 18 | |
| 10 | 2023 | 17 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 10 | |
| 14 | 2022 | 9 | |
| 15 | 2021 | 1 | |
| 16 | 2020 | 69 | |
| 17 | 2019 | 16 | |
| 18 | 2019 | 17 | |
| 19 | 2018 | 44 | |
| 20 | 2016 | 12 |
About Weizhen Liu
Weizhen Liu is a scholar working on Gastroenterology, Cancer Research and Oncology, having authored 65 papers that have together received 1.2k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (11 papers), Gastric Cancer Management and Outcomes (8 papers), Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers), Cancer Mechanisms and Therapy (5 papers), Sarcoma Diagnosis and Treatment (5 papers), RNA Research and Splicing (5 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Biological Psychiatry (41 citations), Gastroenterology (82 citations) and Cancer Research (202 citations). Weizhen Liu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Kaixiong Tao, Xiangyu Zeng, Chuanqing Wu, Tuo Ruan, Yuping Yin, Christian Hölscher, Xiaojie Zhu, Lin Li, Yanwei Li and Ruidong Li. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.